Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of…
By C. Haie-meder, R. Pötter, E. van Limbergen, E. Briot, M. De Brabandere, J. Dimopoulos, I. Dumas, T. Hellebust, C. Kirisits, S. Lang and 5 more. Radiotherapy and Oncology, 2005
1,515 citations recorded by the source corpus.
Subfields: Epidemiology, Obstetrics and Gynecology
View Paper: https://www.semanticscholar.org/paper/e405542cf85706a1b2c0bac472678c6146878529
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Obstetrics and Gynecology
Citations in the corpus
- Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer (2011, background): “…general treatment and the treatment planning characteristics we refer in particular to the preceding report as published before recording the patient population treated from 1998–2003 [13], but also to other publications from the Vienna group describing these procedures in detail [6,7,10,11,35–40].”
- Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. (2006, methodology): “The concepts of GTV and CTV [16] need to be validated through prospective evaluation of clinical practice using 3D imaging for treatment planning and (at present) for recording and reporting.”
- The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies (2018, methodology): “For the CTVIR and GTVres, doses of 60 Gy and 95Gya/b = 10 (D98), respectively, are required for similar levels of local control.”
- Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. (2016, methodology): “For OAR, the mean D2cc for bladder, rectum, sigmoid, and bowel was 81 ± 22 Gy, 64 ± 9 Gy, 66 ± 10 Gy and 64 ± 9 Gy, respectively (all EQD23).”
- Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. (2010, methodology): “The GWG has published several recommendations and results from scientific projects [3,4,9].”